about
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model.Prevention of hepatitis B virus infection: from the past to the future.Advances in therapeutics for chronic hepatitis B.New paradigms in hepatitis B management: only diamonds are forever.An update on the strategies used for the treatment of chronic hepatitis B in children.Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients.In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV RNaseH Inhibitors.CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X.Favorable outcome of extended treatment with adding pegylated Interferonα-2a to entecavir for HBeAg-positive chronic hepatitis B: a case report.A potent human neutralizing antibody Fc-dependently reduces established HBV infectionsImmunotherapy for Chronic Hepatitis B Virus Infection.Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population
P2860
Q30391932-4A24A349-B771-4894-BDCE-478BF3FF32EDQ33683128-2B688D88-3494-4494-8AE1-D5709C5ADAF4Q38354222-67FB6196-8A68-4BCB-9498-9383CCF23530Q38585657-2EAC87C2-0EC4-4278-B1FA-D6F623125704Q38588187-D8281F2A-9A75-4C86-8D35-72CDFB01D579Q38692198-1D180553-6BE1-4A44-9C11-C2B49006ECA7Q38780065-A583D2D0-6F42-4A99-AA91-84427191B49EQ40163118-B80203F8-7E78-4E6B-9AED-B5EE8F2E2B45Q40409344-356B318D-CBA4-43D6-AADB-812FF2FF4954Q40580426-F1E8BFD6-9E80-4D9D-B601-EB156E0E916BQ40832139-641B8489-2F6B-411E-B6D5-58A1AA68A610Q41671765-3A37FB18-C151-42EF-AFB4-8ABB72138B50Q47556416-65D1ADF3-8D5A-4F15-B6E8-216D003F722CQ58707869-20DE291A-8423-4697-8A77-8EE2953D2A30
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hepatitis B: future curative strategies
@ast
Hepatitis B: future curative strategies
@en
Hepatitis B: future curative strategies
@nl
type
label
Hepatitis B: future curative strategies
@ast
Hepatitis B: future curative strategies
@en
Hepatitis B: future curative strategies
@nl
prefLabel
Hepatitis B: future curative strategies
@ast
Hepatitis B: future curative strategies
@en
Hepatitis B: future curative strategies
@nl
P2860
P921
P1476
Hepatitis B: future curative strategies
@en
P2093
Laura Rivino
P2860
P304
P356
10.1097/QCO.0000000000000110
P407
P5008
P577
2014-12-01T00:00:00Z